Mogad

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

Mayo Clinic Laboratories

The pathology of MS and MOGAD: similarities and differences

Current MOGAD criteria and the role of MRI in diagnosis

Predicting relapses in MOGAD

Research developments in MOGAD

MOGAD

Neuro-Ophthalmology with Dr. Andrew G. Lee

Proposed criteria for the diagnosis of MOGAD

Recognizing the Clinical Features of MOGAD for Diagnosis

Mogadishu in Motion | A Ride Around Town

MOGAD (Myelin Oligodendrocyte Glycoprotein Associated Disease) Explained by Neurologist

Dr. Brandon Beaber

Living with NMOSD & MOGAD: Patient Perspectives

The Sumaira Foundation

Advancements in MOGAD diagnosis: key features of the new guidelines

2024 MOGAD Together | Community Q&A

SRNA

2022 Pre-RNDS | MOG Antibody Disease (MOGAD)

SRNA

Assessing predictors of relapse in MOGAD patients

MS & MOGAD: differences in response to immunomodulatory therapies

MOG Antibody Disease (MOGAD) Symptoms & Presentations

Are You Missing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD)?

Should routine MRI surveillance be implemented in NMOSD and MOGAD?

913. Avoiding a Misdiagnosis: Understanding the Differences Between MOGAD, MS, and NMOSD

SRNA